$1.19
-4.0%Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Chief Commercial Officer
Compensation
$274,199
Chief Financial Officer & Treasurer
Compensation
$723,558
Chief Human Resources Officer
Chief Product Officer
Chief Technology Officer
Founder & Executive Director
Compensation
$72,047
General Counsel & Corporate Secretary
Compensation
$490,000
President, Chief Executive Officer & Director
Compensation
$1,060,833
Senior Vice President of Demand Generation & Corporate Brand
During the last 12 months, insiders have purchased $564K and sold $729K worth of QSI shares, resulting in $165K of net selling activity.
0
0.00
308.6K
297.93K
-298K
-$298K
609.9K
564.25K
66.2K
84.48K
+480K
+$480K
0
0.00
122.5K
240.03K
-240K
-$240K
0
0.00
66.2K
106.83K
-107K
-$107K
Kummeth Charles R.
Director
$460K
Dowdy Paula
Director
$104K
Hawkins Jeffrey Alan
Director, Officer: President & Ceo
$291K
Keyes Jeffry R.
Officer: Chief Financial Officer
$120K
Vieceli John S.
Officer: Chief Product Officer
$114K
Rothberg Jonathan M
Director, 10 Percent Owner:
$80K
Lapointe Christian
Officer: Gc & Corp. Secretary
$62K
Slightly bearish with $165K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.
Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 2 buyers. Widespread selling across multiple insiders may signal concerns.
QSI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 01, 2026 | April 01, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 20, 2025 | May 16, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 01, 2024 | May 15, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 29, 2023 | May 11, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | March 29, 2022 | May 10, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.